Angelika Lampert, MD, is the director of the Institute of Neurophysiology at the RWTH Aachen University, Germany. She is the coordinator of the Sodium Channel Network Aachen (SCNAachen) focusing on inherited neuropathic pain syndromes such as small fiber neuropathy linked to sodium channel mutations. Her research concentrates on the translation of laboratory findings to potential clinical treatment, either as a population therapy or personalized medicine. The Lampert lab focusses on:  1) biophysics and structure-function relation of voltage-gated sodium channels and their mutations linked to pain, and 2) induced pluripotent stem cells (iPS-cells) and their differentiation into peripheral sensory neurons as a model for human neuropathies. 

Dr. Lampert studied human medicine in Jena, Germany, and Strasbourg, France, and completed her MD thesis at the Max-Plank working group Molecular and Cellular Biophysics in Jena in 2003. Following postdoctoral training at Yale University in New Haven, CT, Angelika Lampert set up her lab in Erlangen, Germany, before moving to Aachen in 2013. Dr. Lampert is the recipient of awards and grants from the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF) and the German Association of the Study of Pain (DGSS).